CTRI/2019/02/017841已完成2 期
An Open Label Randomized Clinical Study to Evaluate the Efficacy of Virechana and Nasya followed by Dhananjaya Vati in the Management of Dhatwagnimandya with special reference to Hypothyroidism
ational institute of Ayurveda Jaipur0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diagnosed cases of Hypothyroidism on the basis of Serum TSH, T3 and T4 levels.
- •TSH level above 4.5 mU/L up to 100 mU/L
- •Total Serum T4 level less than 4.5 to 12.5 ng/dl
- •Total serum T3 level less than 80 to 220 ng/dl
- •2. Patients having clinical features of Hypothyroidism.
- •3. Patient indicated for Virechana and Nasya.
- •4.Patient willing to participate in the study.
排除标准
- •1.Patients with any chronic and severe systemic disorders like IHD, CVA, Goiter, Uncontrolled Diabetes, CRF, Active malignant disease etc.
- •2. Pregnancy and lactation.
- •3. Patient contraindicated for Virechana and Nasya.
研究者
相似试验
进行中（未招募）
2 期
Management of Ankylosing Spondylitis through AyurvedaCTRI/2019/02/017768ational Institute of Ayurveda
尚未招募
2 期
A Clinical study to evaluate the efficacy and safety of Quista-DN health drink in diabetic individualsCTRI/2019/07/020179The Himalaya Drug Company
已完成
不适用
A study to find the effect of Amla extract in obese peopleCTRI/2019/01/017201Arjuna Natural Ltd58
已完成
2 期
A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infectioCTRI/2020/10/028423PNB Vesper Life Science Pvt Ltd40
已完成
4 期
A clinical study to evaluate the efficacy and safety of Proseventy in dialysis patients.CTRI/2012/03/002516Panacea Biotec Ltd180